Showing 1731-1740 of 3073 results for "".
- Micro-Autologous Fat Transplantation Shows Durable Correction for Gummy Smile in Long-Term Studyhttps://modernaesthetics.com/news/micro-autologous-fat-transplantation-shows-durable-correction-for-gummy-smile-in-long-term-study/2485602/Micro-autologous fat transplantation (MAFT) may offer a durable, minimally invasive option for correcting gummy smile, according to a long-term retrospective study published online ahead of print in Plastic and Reconstructive Surgery. Investigators analyzed outcomes in 52 patients
- New Consensus Algorithm Guides Skincare Use With Energy-Based Acne Treatmentshttps://modernaesthetics.com/news/new-consensus-algorithm-guides-skincare-use-with-energy-based-acne-treatments/2485595/A new consensus-based study published in Journal of Drugs in Dermatology outlines a practical, stepwise algorithm for integrating skincare with energy-based devices (EBDs) in the management of acne and acne sequelae. Titled “Practical Algorithm for Acne Treatment Integrating Skincare
- New JDD Study Explores Aesthetic Motivations of African American Womenhttps://modernaesthetics.com/news/new-jdd-study-explores-aesthetic-motivations-of-african-american-women/2485593/A new survey-based study published in Journal of Drugs in Dermatology examines the cosmetic concerns, motivations, and skincare behaviors that shape the aesthetic journey of African American (AA) women, highlighting hair loss and hyperpigmentation as leading priorities in this population
- Octane Aesthetics Tech Forum Panelists React to FDA Approval of Oral Semaglutidehttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-react-to-fda-approval-of-oral-semaglutide/2485572/At the 2026 Octane Aesthetics Tech Forum, panelists weighed in on the recent FDA approval of oral semaglutide, offering a mix of cautious optimism and clinical realism. While the approval marks a milestone in expanding GLP-1 receptor agonist (RA) access, most experts on the panel said oral versio
- Octane Aesthetics Tech Forum: Panelists Discuss Innovation in Hair Loss Delivery, Regulationhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-discuss-innovation-in-hair-loss-delivery-regulation/2485561/The future of hair restoration may be rooted in regenerative science, but panelists at the Octane Aesthetics Tech Forum agree: the real-world success of these advances hinges on how treatments are delivered and how they’re regulated. Speaking during the “Hiding in the Shadows of H
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Octane Aesthetics Tech Forum: 3 Big Trends from GuidePoint Qsight’s 2025 Market Analysishttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-3-big-trends-from-guidepoint-qsights-2025-market-analysis/2485514/At the 2026 Octane Aesthetic Tech Forum, Erik Haines, Managing Director of Guidepoint Qsight, presented a data-rich snapshot of the state of the medical aesthetics industry. Drawing from over $17 billion in transactional data across 45,000 aesthetic practices and millions of patient records, Hain
- Tranexamic Acid in Tumescent Solution Reduces Bruising and Pain After Arm Liposuctionhttps://modernaesthetics.com/news/tranexamic-acid-in-tumescent-solution-reduces-bruising-and-pain-after-arm-liposuction/2485477/New research indicates tranexamic acid (TXA) reduced early postoperative pain and ecchymosis when added to tumescent solution during arm liposuction. The researchers, publishing in Plastic and Reconstructive Surgery, conducted a double-blind, randomized contralateral study that in
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz
- Podium Introduces Artificial Intelligence Operating System Designed for Aesthetic Practiceshttps://modernaesthetics.com/news/podium-introduces-artificial-intelligence-operating-system-designed-for-aesthetic-practices/2485420/Podium has announced the launch of an artificial intelligence (AI)–driven operating system designed specifically for aesthetic practices, positioning the platform as a unified alternative to the fragmented software ecosystems common in cosmetic dermatology practices. The company describes the pro